liposomal daunorubicin, an aqueous solution of the citrate salt of daunorubicin encapsulated within specifically constructed liposomes that shows enhanced selectivity for solid tumors in situ compared with that of the hydrochloride salt. It is administered intravenously in the treatment of advanced Kaposi’s sarcoma associated with acquired immunodeficiency syndrome.
